newsfilter
← Latest News
GlobeNewswire·

vTv Therapeutics Announces 2024 Third Quarter Financial Results and Provides Corporate Update

HIGH POINT, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (NASDAQ:VTVT), a clinical stage biopharmaceutical company with a portfolio of novel small molecules and a lead program in diabetes, today